Ubs Group Ag Natera, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Natera, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 197,954 shares of NTRA stock, worth $31.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

197,954

Previous 267,761 26.07%

Holding current value

$31.6 Million

Previous $29 Million 13.23%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$97.75 - $129.67 $6.82 Million - $9.05 Million	-69,807 Reduced 26.07%	197,954 $25.2 Million
Q2 2024 Aug 13, 2024	BUY	$85.28 - $112.6 $9.52 Million - $12.6 Million	111,610 Added 71.48%	267,761 $29 Million
Q1 2024 May 13, 2024	BUY	$59.21 - $92.9 $413,226 - $648,349	6,979 Added 4.68%	156,151 $14.3 Million
Q4 2023 Feb 09, 2024	BUY	$37.55 - $62.64 $4.33 Million - $7.23 Million	115,400 Added 341.7%	149,172 $9.34 Million
Q3 2023 Nov 09, 2023	SELL	$43.4 - $62.52 $510,123 - $734,860	-11,754 Reduced 25.82%	33,772 $1.49 Million
Q2 2023 Aug 11, 2023	SELL	$47.08 - $55.16 $1.54 Million - $1.81 Million	-32,725 Reduced 41.82%	45,526 $2.22 Million
Q1 2023 May 12, 2023	SELL	$36.57 - $58.29 $1.85 Million - $2.95 Million	-50,525 Reduced 39.23%	78,251 $4.34 Million
Q4 2022 Feb 08, 2023	BUY	$34.17 - $47.91 $2.52 Million - $3.53 Million	73,622 Added 133.48%	128,776 $5.17 Million
Q3 2022 Nov 10, 2022	BUY	$36.93 - $56.68 $536,592 - $823,560	14,530 Added 35.77%	55,154 $2.42 Million
Q2 2022 Aug 10, 2022	SELL	$28.13 - $44.54 $2.27 Million - $3.59 Million	-80,705 Reduced 66.52%	40,624 $1.44 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $3.05 Million - $9.19 Million	100,664 Added 487.12%	121,329 $4.94 Million
Q4 2021 Feb 14, 2022	SELL	$86.26 - $119.0 $1.68 Million - $2.32 Million	-19,519 Reduced 48.57%	20,665 $1.93 Million
Q3 2021 Nov 15, 2021	SELL	$100.17 - $126.36 $1.02 Million - $1.28 Million	-10,138 Reduced 20.15%	40,184 $4.48 Million
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $1.18 Million - $1.64 Million	13,702 Added 37.42%	50,322 $5.71 Million
Q1 2021 May 12, 2021	SELL	$91.47 - $124.36 $1.36 Million - $1.85 Million	-14,857 Reduced 28.86%	36,620 $3.72 Million
Q4 2020 Feb 11, 2021	BUY	$66.66 - $111.74 $2.46 Million - $4.12 Million	36,882 Added 252.7%	51,477 $5.12 Million
Q3 2020 Nov 12, 2020	SELL	$45.89 - $72.67 $333,436 - $528,020	-7,266 Reduced 33.24%	14,595 $1.05 Million
Q2 2020 Jul 31, 2020	BUY	$26.36 - $49.86 $336,669 - $636,811	12,772 Added 140.52%	21,861 $1.09 Million
Q1 2020 May 01, 2020	BUY	$17.27 - $40.17 $14,904 - $34,666	863 Added 10.49%	9,089 $272,000
Q4 2019 Feb 14, 2020	SELL	$32.1 - $40.4 $5.11 Million - $6.43 Million	-159,254 Reduced 95.09%	8,226 $277,000
Q3 2019 Nov 14, 2019	BUY	$25.38 - $34.89 $1.87 Million - $2.57 Million	73,615 Added 78.43%	167,480 $5.49 Million
Q2 2019 Aug 14, 2019	BUY	$17.75 - $27.58 $1.6 Million - $2.49 Million	90,189 Added 2453.45%	93,865 $2.59 Million
Q1 2019 May 14, 2019	SELL	$11.34 - $20.62 $2.12 Million - $3.86 Million	-187,083 Reduced 98.07%	3,676 $76,000
Q4 2018 Feb 14, 2019	BUY	$12.32 - $24.38 $1.58 Million - $3.12 Million	127,961 Added 203.77%	190,759 $2.66 Million
Q3 2018 Nov 14, 2018	BUY	$18.82 - $28.96 $1.02 Million - $1.57 Million	54,071 Added 619.58%	62,798 $1.5 Million
Q2 2018 Aug 14, 2018	BUY	$8.79 - $19.98 $63,991 - $145,454	7,280 Added 503.11%	8,727 $164,000
Q1 2018 May 15, 2018	SELL	$9.0 - $11.95 $25,974 - $34,487	-2,886 Reduced 66.61%	1,447 $13,000
Q4 2017 Feb 14, 2018	BUY	$8.99 - $14.31 $3,497 - $5,566	389 Added 9.86%	4,333 $39,000
Q3 2017 Nov 14, 2017	SELL	$8.02 - $13.33 $2,638 - $4,385	-329 Reduced 7.7%	3,944 $51,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,278 Added 114.19%	4,273 $46,000
Q1 2017 Nov 14, 2017	BUY	N/A	1,995	1,995 $18,000

Others Institutions Holding NTRA

# of Institutions

527

Shares Held

118M

Call Options Held

308K

Put Options Held

191K

View Full List

About Natera, Inc.

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $15.5B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

More about NTRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account